Veeraballi Sindhusha, Mirza Noreen, Khawar Zaineb, Shaaban Hamid
Internal Medicine, Saint Michael's Medical Center, Newark, USA.
Internal Medicine, St. George's University School of Medicine, Newark, USA.
Cureus. 2022 Jul 11;14(7):e26738. doi: 10.7759/cureus.26738. eCollection 2022 Jul.
Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B cell lymphomas. MZL originates from the mature B lymphocytes, which are usually present in the marginal zone of the lymphoid follicle. Histological transformation (HT) is defined as sheets of large cells arising in an indolent lymphoma with morphological and immunophenotypic changes suggestive of a high-grade lymphoma such as Hodgkin's lymphoma, diffuse large B cell lymphoma (DLBCL), or Burkitt lymphoma. The median time of transformation ranges from one year to 15 years following the initial diagnosis of MZL. Studies reported that the deletion of TP53 and 7q and mutations in NOTCH2 are commonly associated with HT in MZL. This case report outlines the rare happening of an MZL transformation into a nodular subtype of Hodgkin's lymphoma in a 56-year-old female, which prompted further investigations and a different therapeutic approach. By reporting this case, we emphasize that HT changes the natural history and significantly affects the overall survival of patients with MZL. Hence, it is necessary to get a core needle or excisional biopsy whenever there is a clinical suspicion of HT in MZL for early diagnosis and a better therapeutic approach.
边缘区淋巴瘤(MZL)是一种罕见的、生长缓慢/惰性的B细胞淋巴瘤,占所有B细胞淋巴瘤的10.5%至11.8%。MZL起源于成熟B淋巴细胞,这些细胞通常存在于淋巴滤泡的边缘区。组织学转化(HT)定义为在惰性淋巴瘤中出现大片大细胞,伴有形态学和免疫表型改变,提示为高级别淋巴瘤,如霍奇金淋巴瘤、弥漫性大B细胞淋巴瘤(DLBCL)或伯基特淋巴瘤。转化的中位时间在MZL初始诊断后的1年至15年之间。研究报告称,TP53和7q缺失以及NOTCH2突变通常与MZL中的HT相关。本病例报告概述了一名56岁女性中罕见的MZL转化为结节型霍奇金淋巴瘤的情况,这促使了进一步的调查和不同的治疗方法。通过报告此病例,我们强调HT改变了自然病程,并显著影响MZL患者的总生存期。因此,当临床上怀疑MZL发生HT时,有必要进行粗针穿刺活检或切除活检,以便早期诊断并采取更好的治疗方法。